Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,728 | 49,635 | 419 | 0 | 0 |
| TOTAL | $46,857 | $51,255 | $438 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 35 | N/A | N/A | N/A | N/A |
| Investments And Advances | 0 | 50 | 0 | 0 | 0 |
| Other Non-Current Assets | 141 | 0 | 1,822 | 0 | 0 |
| TOTAL | $176 | $50 | $1,822 | $N/A | $N/A |
| Total Assets | $47,033 | $51,306 | $2,259 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 455 | 1,826 | 3,083 | 0 | 0 |
| Accrued Expenses | 1,060 | 1,207 | 1,325 | 0 | 0 |
| TOTAL | $1,607 | $3,033 | $4,409 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 0 | 21,065 | 0 | 0 |
| TOTAL | $32 | $N/A | $21,065 | $N/A | $N/A |
| Total Liabilities | $1,638 | $3,033 | $25,473 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,966 | 15,966 | 10,964 | N/A | N/A |
| Common Shares | 16 | 16 | 0 | 0 | 0 |
| Retained earnings | -32,693 | -29,254 | -26,163 | 0 | 0 |
| TOTAL | $45,395 | $48,272 | $-23,214 | $0 | $0 |
| Total Liabilities And Equity | $47,033 | $51,306 | $2,259 | $0 | $0 |